Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

TYRATyra Biosciences, Inc.

Nasdaq · CIK 0001863127
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts213

Identity from submissions API

NameTyra Biosciences, Inc.
CIK0001863127
TickersTYRA
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN831476348
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(619) 728-4760
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
2656 STATE STREET
CARLSBAD
CA
92008
CA
Mailing address
2656 STATE STREET
CARLSBAD
CA
92008
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

428 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-10 10-Q 10-Q 0001193125-26-454481 001-40800 261538063 34 8898818 1 1
2026-11-10 8-K 8-K 2.02,9.01 0001193125-26-454474 001-40800 261538045 34 817837 1 1
2026-10-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-003856 005-92865 261491716 34 10914
2026-09-21 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000921895-26-002613 005-92865 261394744 34 38612
2026-09-17 4 4 0001193125-26-394738 4760
2026-09-17 4 4 0001193125-26-394734 4999
2026-09-17 4 4 0001193125-26-394731 4780
2026-09-17 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001346824-26-000237 005-92865 261387274 34 20199
2026-09-17 4 xslF345X06/form4-09172026_080941.xml 0001231919-26-001194 14107
2026-09-17 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-108569 005-92865 261386881 34 16362
2026-09-15 8-K 8-K 8.01,9.01 0001193125-26-390951 001-40800 261378814 34 561196 1 1
2026-09-15 424B5 424B5 0001193125-26-390947 333-298911 261378807 33 726672 1 1
2026-09-14 FWP FWP 0001193125-26-389801 333-298911 261375762 34 90470
2026-09-14 S-3ASR S-3ASR 0001193125-26-389752 333-298911 261375718 33 797381 1 1
2026-09-11 4 4 0001193125-26-389333 4942
2026-09-09 8-K 8-K 8.01 0001193125-26-385886 001-40800 261366662 34 168408 1 1
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001804218-26-000003 005-92865 261283056 34 14748
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000908834-26-000427 005-92865 261276358 34 47658
2026-08-04 424B5 424B5 0001193125-26-333055 333-287086 261239856 33 40514
2026-08-04 10-Q 10-Q 0001193125-26-332995 001-40800 261239561 34 9183478 1 1
2026-08-04 8-K 8-K 2.02,9.01 0001193125-26-332752 001-40800 261238478 34 805838 1 1
2026-07-30 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-003114 005-92865 261221092 34 10864
2026-06-26 144 xsl144X01/primary_doc.xml 0001628280-26-045813 001-40800 261130214 33 7485
2026-06-02 8-K 8-K 5.07 0001193125-26-253435 001-40800 261055755 34 146212 1 1
2026-06-01 4 xslF345X06/form4-06012026_090607.xml 0001231919-26-000590 14574
2026-06-01 4 4 0001193125-26-251539 5686
2026-06-01 4 4 0001193125-26-251538 5648
2026-06-01 4 4 0001193125-26-251537 6470
2026-06-01 4 4 0001193125-26-251536 5677
2026-06-01 4 4 0001193125-26-251534 5683
2026-06-01 4 4 0001193125-26-251532 5715
2026-06-01 144 xsl144X01/primary_doc.xml 0001628280-26-039506 001-40800 261051052 33 4866
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001831942-26-000022 005-92865 26987945 34 14921
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001274173-26-000153 005-92865 26985002 34 11995
2026-05-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-224263 005-92865 26980095 34 6691
2026-05-13 10-Q 10-Q 0001193125-26-220645 001-40800 26970996 34 7413480 1 1
2026-05-13 8-K 8-K 2.02,9.01 0001193125-26-220638 001-40800 26970983 34 768512 1 1
2026-05-12 144 xsl144X01/primary_doc.xml 0001628280-26-034243 001-40800 26970059 33 6438
2026-05-12 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000908834-26-000228 005-92865 26966054 34 57964
2026-05-07 4 4 0001193125-26-212116 7381
2026-05-07 4 4 0001193125-26-212115 7362
2026-05-07 4 4 0001193125-26-212114 7345
2026-05-07 4 4 0001193125-26-212112 7402
2026-05-07 4 4 0001193125-26-212111 7314
2026-04-24 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-177291 005-92865 26894138 34 12131
2026-04-20 4 4 0001193125-26-164090 5335
2026-04-20 3 3 0001193125-26-164080 16585
2026-04-17 ARS ARS 0001193125-26-160368 001-40800 26869481 34 1297855
2026-04-17 DEFA14A DEFA14A 0001193125-26-160364 001-40800 26869478 34 457783
2026-04-17 DEF 14A DEF 14A 0001193125-26-160360 001-40800 26869474 34 1835046 1 1
2026-04-17 8-K 8-K 5.02 0001193125-26-160347 001-40800 26869448 34 142169 1 1
2026-04-13 144 xsl144X01/primary_doc.xml 0001628280-26-024915 001-40800 26858297 33 5800
2026-04-07 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-000723 005-92865 26844062 34 11549
2026-04-02 3 3 0001193125-26-140314 22116
2026-04-02 8-K 8-K 5.02 0001193125-26-140027 001-40800 26833181 34 137020 1 1
2026-03-27 4 4 0001193125-26-129239 13735
2026-03-26 144 xsl144X01/primary_doc.xml 0001950047-26-003016 001-40800 26798041 33 5403
2026-03-25 144 xsl144X01/primary_doc.xml 0001950047-26-003004 001-40800 26793668 33 4713
2026-03-17 4 4 0001193125-26-111100 4531
2026-03-17 4 4 0001193125-26-111083 4511
2026-03-12 144 xsl144X01/primary_doc.xml 0001628280-26-017387 001-40800 26749219 33 5945
2026-03-06 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001346824-26-000068 005-92865 26731416 34 17392
2026-03-04 8-K 8-K 8.01 0001193125-26-091880 001-40800 26722781 34 136452 1 1
2026-03-02 10-K 10-K 0001193125-26-085490 001-40800 26708107 34 13418745 1 1
2026-03-02 8-K 8-K 2.02,9.01 0001193125-26-085399 001-40800 26707632 34 811402 1 1
2026-02-20 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000908834-26-000101 005-92865 26656747 34 47467
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000921895-26-000475 005-92865 26642080 34 23026
2026-02-13 4 4 0001193125-26-051534 6662
2026-02-13 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-26-051514 005-92865 26633522 34 6486
2026-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-26-051409 005-92865 26632997 34 12648
2026-02-12 144 xsl144X01/primary_doc.xml 0001628280-26-007756 001-40800 26627276 33 7674
2026-01-20 4 4 0001193125-26-016651 6666
2026-01-12 144 xsl144X01/primary_doc.xml 0001628280-26-001882 001-40800 26527916 33 7672
2025-12-19 4 4 0001193125-25-327254 5093
2025-12-16 4 4 0001193125-25-320941 4919
2025-12-12 144 xsl144X01/primary_doc.xml 0001628280-25-056777 001-40800 251568414 33 6990
2025-12-01 4 4 0001193125-25-304160 5305
2025-12-01 3 3 0001193125-25-304157 18139
2025-12-01 8-K 8-K 5.02 0001193125-25-303162 001-40800 251537172 34 144984 1 1
2025-11-25 4 4 0001193125-25-297551 5435
2025-11-21 144 xsl144X01/primary_doc.xml 0001628280-25-053608 001-40800 251508349 33 5022
2025-11-19 4 4 0001193125-25-288529 6665
2025-11-18 144 xsl144X01/primary_doc.xml 0001628280-25-052968 001-40800 251495709 33 5953
2025-11-17 4 4 0001193125-25-284935 10154
2025-11-17 144 xsl144X01/primary_doc.xml 0001628280-25-052618 001-40800 251491389 33 5266
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001831942-25-000025 005-92865 251487319 34 14805
2025-11-14 144 xsl144X01/primary_doc.xml 0001628280-25-052382 001-40800 251486982 33 4799
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-004987 005-92865 251485627 34 10750
2025-11-13 144 xsl144X01/primary_doc.xml 0001628280-25-052140 001-40800 251480015 33 4230
2025-11-05 10-Q 10-Q 0001193125-25-266967 001-40800 251454170 34 8681606 1 1
2025-11-05 8-K 8-K 2.02,9.01 0001193125-25-266916 001-40800 251453994 34 806820 1 1
2025-09-17 4 4 0001193125-25-206439 4531
2025-08-22 8-K 8-K 8.01 0001193125-25-185553 001-40800 251242089 34 140336 1 1
2025-08-14 10-Q 10-Q 0000950170-25-108899 001-40800 251219474 34 8496346 1 1
2025-08-14 8-K 8-K 2.02,9.01 0000950170-25-108876 001-40800 251219144 34 802526 1 1
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000243 005-92865 251215991 34 9419
2025-08-07 4 4 0000950170-25-105153 5263
2025-08-07 4 4 0000950170-25-105140 5253
2025-08-07 4 4 0000950170-25-105132 5331
2025-08-07 4 4 0000950170-25-105128 5241
2025-06-30 8-K 8-K 8.01 0001193125-25-152016 001-40800 251088811 34 141507 1 1
2025-06-20 4 4 0000950170-25-088602 6232
2025-06-18 144 xsl144X01/primary_doc.xml 0001950047-25-004456 001-40800 251056806 33 8141
2025-06-17 144 xsl144X01/primary_doc.xml 0001950047-25-004435 001-40800 251053588 33 7452
2025-06-16 4 xslF345X05/form4-06172025_120645.xml 0001415889-25-017446 18926
2025-06-16 4 4 0000950170-25-086960 8576
2025-06-16 144 xsl144X01/primary_doc.xml 0001950047-25-004335 001-40800 251050230 33 6771
2025-06-13 144 xsl144X01/primary_doc.xml 0001950047-25-004268 001-40800 251046912 33 6085
2025-06-12 144 xsl144X01/primary_doc.xml 0001950047-25-004239 001-40800 251043182 33 4707
2025-06-11 4 xslF345X05/form4-06112025_110646.xml 0001415889-25-016759 14716
2025-06-06 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001415889-25-016006 005-92865 251031796 34 75664
2025-06-06 4 xslF345X05/form4-06062025_080635.xml 0001415889-25-015998 16817
2025-06-02 4 xslF345X05/form4-06022025_080640.xml 0001415889-25-015139 14152
2025-06-02 4 4 0000950170-25-080232 5548
2025-06-02 4 4 0000950170-25-080231 6317
2025-06-02 4 4 0000950170-25-080230 5545
2025-06-02 4 4 0000950170-25-080228 5510
2025-06-02 4 4 0000950170-25-080227 5577
2025-06-02 4 4 0000950170-25-080226 5634
2025-05-29 8-K 8-K 5.07 0001193125-25-130670 001-40800 251003745 34 144640 1 1
2025-05-16 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-001644 333-287086 25961392 33 1703
2025-05-15 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-002398 005-92865 25953228 34 15066
2025-05-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001641172-25-010261 005-92865 25945323 34 16170
2025-05-14 CORRESP filename1.htm 0001193125-25-119821 6626
2025-05-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000122 005-92865 25943757 34 9297
2025-05-12 UPLOAD filename1.pdf 0000000000-25-005033 333-287086 39965
2025-05-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-001603 005-92865 25933365 34 11275
2025-05-08 S-3 S-3 0001193125-25-116008 333-287086 25926784 33 984230
2025-05-08 10-Q 10-Q 0000950170-25-066942 001-40800 25926120 34 7821604 1 1
2025-05-08 8-K 8-K 2.02,9.01 0000950170-25-066924 001-40800 25925972 34 777019 1 1
2025-04-18 ARS ARS 0001193125-25-085713 001-40800 25850337 34 1267464
2025-04-18 DEFA14A DEFA14A 0001193125-25-085711 001-40800 25850332 34 453637
2025-04-18 DEF 14A DEF 14A 0001193125-25-085709 001-40800 25850325 34 1789464 1 1
2025-03-31 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001415889-25-009254 005-92865 25794454 34 21293
2025-03-27 10-K 10-K 0000950170-25-046124 001-40800 25779789 34 14273668 1 1
2025-03-27 8-K 8-K 2.02,9.01 0000950170-25-046064 001-40800 25779336 34 802608 1 1
2025-03-18 4 4 0000950170-25-041551 4518
2025-03-18 4 4 0000950170-25-041550 4538
2025-03-06 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-034972 005-92865 25716664 34 115193
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000921895-25-000495 005-92865 25629389 34 23461
2025-02-07 4 4 0000950170-25-016385 7540
2025-02-05 144 xsl144X01/primary_doc.xml 0001969223-25-000034 001-40800 25594695 33 10325
2025-02-05 144 xsl144X01/primary_doc.xml 0001969223-25-000032 001-40800 25593940 33 10417
2025-01-31 4 4 0000950170-25-011737 5211
2025-01-31 3 3 0000950170-25-011728 18622
2025-01-29 8-K 8-K 5.02 0001193125-25-015646 001-40800 25569341 34 149773 1 1
2025-01-27 4 4 0000950170-25-009278 6695
2025-01-22 144 xsl144X01/primary_doc.xml 0001972362-25-000030 001-40800 25547070 33 4173
2025-01-21 4 4 0000950170-25-007426 32019
2025-01-21 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-007278 005-92865 25542823 34 386670
2024-12-09 144 xsl144X01/primary_doc.xml 0001972362-24-001830 001-40800 241536461 33 7134
2024-12-06 SC 13D/A ff4209876_13da6-tyra.htm 0000895345-24-000607 005-92865 241533642 34 115344
2024-12-05 144 xsl144X01/primary_doc.xml 0001972362-24-001812 001-40800 241529377 33 6537
2024-12-02 144 xsl144X01/primary_doc.xml 0001972362-24-001790 001-40800 241520522 33 5941
2024-11-26 4 4 0000950170-24-131084 7545
2024-11-20 144 xsl144X01/primary_doc.xml 0001972362-24-001695 001-40800 241480762 33 5347
2024-11-19 SC 13D/A ff4142386_13da5-tyra.htm 0000895345-24-000595 005-92865 241478022 34 295232
2024-11-14 144 xsl144X01/primary_doc.xml 0001972362-24-001648 001-40800 241464808 33 4750
2024-11-14 SC 13G/A SC 13G/A 0001104659-24-119312 005-92865 241464752 34 119526
2024-11-14 SC 13G/A AMENDMENT NO. 2 TO SCHEDULE 13G 0000921895-24-002728 005-92865 241463340 34 283776
2024-11-13 SC 13D/A SC 13D/A 0001104659-24-117861 005-92865 241456030 34 144702
2024-11-13 4 xslF345X05/form4-11132024_051102.xml 0001415889-24-026718 14191
2024-11-12 SC 13G/A filing.txt 0000315066-24-002868 005-92865 241444969 34 8108
2024-11-08 4 4 0000950170-24-124184 11169
2024-11-07 10-Q 10-Q 0000950170-24-123346 001-40800 241435854 34 7504450 1 1
2024-11-07 8-K 8-K 2.02,9.01 0000950170-24-123286 001-40800 241435528 34 706947 1 1
2024-11-06 4 4 0000950170-24-122639 11163
2024-11-01 4 4 0000950170-24-120198 35826
2024-11-01 4 4 0000950170-24-120099 4716
2024-10-30 144 xsl144X01/primary_doc.xml 0001969223-24-000750 001-40800 241410196 33 4387
2024-10-30 144 xsl144X01/primary_doc.xml 0001969223-24-000749 001-40800 241410195 33 4468
2024-10-28 144 xsl144X01/primary_doc.xml 0001972362-24-001441 001-40800 241401840 33 4154
2024-10-28 8-K 8-K 8.01 0001193125-24-244590 001-40800 241398414 34 153988 1 1
2024-10-25 8-K 8-K 5.02,7.01,8.01,9.01 0001193125-24-243475 001-40800 241394328 34 3571248 1 1
2024-10-22 SC 13D/A ff4025175_13da4-tyra.htm 0000895345-24-000460 005-92865 241387629 34 209225
2024-10-22 4 xslF345X05/form4.xml 0000895345-24-000458 8388
2024-10-22 3 xslF345X02/form3.xml 0000895345-24-000456 6124
2024-10-22 4 4 0000950170-24-116345 8393
2024-10-22 SC 13D/A SC 13D/A 0001104659-24-110611 005-92865 241387028 34 96497
2024-10-22 4 xslF345X05/form4-10222024_091047.xml 0001415889-24-025522 17480
2024-10-18 8-K 8-K 3.02,9.01 0001193125-24-239650 001-40800 241381022 34 246605 1 1
2024-10-17 4 4 0000950170-24-115432 13288
2024-10-16 144 xsl144X01/primary_doc.xml 0001971857-24-000678 001-40800 241375552 33 14797
2024-10-15 SC 13D/A ff3997312_13da-tyraboxcap.htm 0000895345-24-000430 005-92865 241373152 34 244072
2024-10-15 SC 13D/A ff3991156_13da3-tyra.htm 0000895345-24-000423 005-92865 241373033 34 102875
2024-10-02 4 4 0000950170-24-111702 4555
2024-09-25 4 4 0000950170-24-109410 8387
2024-09-20 4 4 0000950170-24-108533 9489
2024-09-20 144 xsl144X01/primary_doc.xml 0001971857-24-000597 001-40800 241313941 33 10292
2024-09-18 144 xsl144X01/primary_doc.xml 0001971857-24-000581 001-40800 241308053 33 4382
2024-09-18 144 xsl144X01/primary_doc.xml 0001971857-24-000578 001-40800 241307503 33 4671
2024-09-18 144 xsl144X01/primary_doc.xml 0001971857-24-000577 001-40800 241307392 33 4715
2024-09-18 144 xsl144X01/primary_doc.xml 0001971857-24-000576 001-40800 241307367 33 4715
2024-09-18 144 xsl144X01/primary_doc.xml 0001971857-24-000574 001-40800 241307228 33 4737
2024-09-17 4 4 0000950170-24-107399 4520
2024-09-17 4 4 0000950170-24-107391 4539
2024-09-10 4 4 0000950170-24-105200 5341
2024-09-10 3 3 0000950170-24-105193 16917
2024-08-16 4 4 0000950170-24-098179 5261
2024-08-16 4 4 0000950170-24-098175 5249
2024-08-16 4 4 0000950170-24-098150 5271
2024-08-07 10-Q 10-Q 0000950170-24-092778 001-40800 241183755 34 6864689 1 1
2024-08-07 8-K 8-K 2.02,9.01 0000950170-24-092756 001-40800 241183605 34 703184 1 1
2024-06-18 4 4 0000950170-24-074996 6497
2024-06-10 4 4 0000950170-24-071500 6327
2024-06-07 144 xsl144X01/primary_doc.xml 0001971857-24-000366 001-40800 241028936 33 4817
2024-05-31 4 xslF345X05/form4-05312024_100503.xml 0001415889-24-015092 14181
2024-05-31 4 4 0000950170-24-067360 6325
2024-05-31 4 4 0000950170-24-067363 6230
2024-05-31 4 4 0000950170-24-067357 5556
2024-05-31 4 4 0000950170-24-067354 5642
2024-05-31 4 4 0000950170-24-067361 5553
2024-05-31 4 4 0000950170-24-067351 5574
2024-05-31 8-K 8-K 3.03,5.03,5.07,9.01 0001193125-24-151705 001-40800 241009521 34 174492 1 1
2024-05-09 4 4 0000950170-24-057201 5168
2024-05-09 3 3 0000950170-24-057194 16545
2024-05-09 4 4 0000950170-24-057192 5235
2024-05-09 3 3 0000950170-24-057184 16640
2024-05-09 10-Q 10-Q 0000950170-24-056971 001-40800 24930745 34 6490212 1 1
2024-05-09 8-K 8-K 2.02,9.01 0000950170-24-056935 001-40800 24930583 34 660902 1 1
2024-05-07 DEFA14A DEFA14A 0001193125-24-133190 001-40800 24922592 34 44274
2024-05-07 8-K 8-K 5.02 0001193125-24-133170 001-40800 24922434 34 150871 1 1
2024-04-22 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-04-22 16:00:00 9999999995-24-001069 333-278068 24862584 33 1710
2024-04-18 CORRESP filename1.htm 0001193125-24-100772 5826
2024-04-18 ARS ARS 0001193125-24-100762 001-40800 24854319 34 14139046
2024-04-18 DEFA14A DEFA14A 0001193125-24-100758 001-40800 24854298 34 176407
2024-04-18 DEF 14A DEF 14A 0001193125-24-100755 001-40800 24854287 34 565894
2024-04-05 PRE 14A PRE 14A 0001193125-24-088494 001-40800 24826790 34 535312
2024-03-22 UPLOAD filename1.pdf 0000000000-24-003168 333-278068 40199
2024-03-19 4 4 0000950170-24-033848 4538
2024-03-19 4 4 0000950170-24-033845 4525
2024-03-19 4 4 0000950170-24-033814 4519
2024-03-19 S-8 S-8 0001193125-24-071370 333-278069 24763980 33 97955
2024-03-19 S-3 S-3 0001193125-24-071361 333-278068 24763937 33 287701
2024-03-19 10-K 10-K 0000950170-24-033461 001-40800 24763263 34 12802078 1 1
2024-03-19 8-K 8-K 2.02,9.01 0000950170-24-033455 001-40800 24763061 34 703104 1 1
2024-03-13 4 4 0000950170-24-030932 4583
2024-03-11 SC 13G/A filing.txt 0000315066-24-001667 005-92865 24736627 34 8078
2024-03-08 4 4 0000950170-24-028807 6326
2024-03-05 4 4 0000950170-24-026365 8413
2024-02-29 4 4 0000950170-24-023406 8070
2024-02-14 4 4 0000950170-24-015559 4584
2024-02-14 SC 13G/A AMENDMENT NO. 1 TO SCHEDULE 13G 0000921895-24-000434 005-92865 24633061 34 279468
2024-02-13 D xslFormDX01/primary_doc.xml 06b 0001944599-24-000001 021-505161 24626712 33 14302
2024-02-12 144 xsl144X01/primary_doc.xml 0002007317-24-000112 001-40800 24620756 33 5980
2024-02-09 4 4 0000950170-24-013474 4925
2024-02-09 SC 13G/A filing.txt 0000315066-24-001576 005-92865 24612683 34 8081
2024-02-08 4 xslF345X05/form4-02082024_100255.xml 0001415889-24-003043 16820
2024-02-08 SC 13D/A ff3002908_13da-tyra.htm 0000895345-24-000036 005-92865 24610115 34 231489
2024-02-08 4 xslF345X05/form4.xml 0000895345-24-000035 14342
2024-02-06 4 4 0000950170-24-011880 11988
2024-02-06 4 4 0000950170-24-011879 8359
2024-02-06 144 xsl144X01/primary_doc.xml 0002007317-24-000076 001-40800 24601011 33 4794
2024-02-06 SC 13D/A SC 13D/A 0001104659-24-011140 005-92865 24600843 34 105797
2024-02-05 8-K 8-K 1.01,3.02,7.01,9.01 0001193125-24-023367 001-40800 24593821 34 550830 1 1
2024-02-02 144 xsl144X01/primary_doc.xml 0002007317-24-000063 001-40800 24592566 33 4736
2024-02-02 144 xsl144X01/primary_doc.xml 0002007317-24-000062 001-40800 24592304 33 4211
2024-02-01 8-K 8-K 8.01 0001193125-24-021953 001-40800 24587990 34 150292 1 1
2023-12-22 8-K 8-K 8.01 0001193125-23-301829 001-40800 231507394 34 152721 1 1
2023-11-07 10-Q 10-Q 0000950170-23-060276 001-40800 231384149 34 6435231 1 1
2023-11-07 8-K 8-K 2.02,9.01 0000950170-23-060235 001-40800 231383716 34 330639 1 1
2023-10-26 8-K 8-K 5.03,9.01 0001193125-23-264152 001-40800 231350825 34 658286 1 1
2023-09-19 4 FORM 4 SUBMISSION 0001209191-23-050094 4641
2023-09-19 4 FORM 4 SUBMISSION 0001209191-23-050092 4636
2023-09-19 4 FORM 4 SUBMISSION 0001209191-23-050090 4656
2023-08-10 10-Q 10-Q 0000950170-23-041382 001-40800 231159955 34 6969111 1 1
2023-08-10 8-K 8-K 2.02,9.01 0000950170-23-041368 001-40800 231159868 34 365447 1 1
2023-08-01 4 FORM 4 SUBMISSION 0001209191-23-044047 5373
2023-08-01 4 FORM 4 SUBMISSION 0001209191-23-044044 5366
2023-08-01 4 FORM 4 SUBMISSION 0001209191-23-044035 5412
2023-08-01 4 FORM 4 SUBMISSION 0001209191-23-044027 5377
2023-07-21 4 FORM 4 SUBMISSION 0001209191-23-043165 14215
2023-07-17 4 FORM 4 SUBMISSION 0001209191-23-042495 14551
2023-07-12 4 FORM 4 SUBMISSION 0001209191-23-042114 20143
2023-07-03 4 FORM 4 SUBMISSION 0001209191-23-040654 22015
2023-06-28 4 FORM 4 SUBMISSION 0001209191-23-040105 23962
2023-06-26 4 FORM 4 SUBMISSION 0001209191-23-039807 10855
2023-06-23 144 xsl144X01/primary_doc.xml 0001971857-23-000305 001-40800 231037499 33 9289
2023-06-21 4 FORM 4 SUBMISSION 0001209191-23-038945 16654
2023-06-16 144 xsl144X01/primary_doc.xml 0001971857-23-000290 001-40800 231021883 33 5187
2023-06-16 144 xsl144X01/primary_doc.xml 0001971857-23-000289 001-40800 231021810 33 5179
2023-06-16 144 xsl144X01/primary_doc.xml 0001971857-23-000288 001-40800 231021731 33 5171
2023-06-16 144 xsl144X01/primary_doc.xml 0001971857-23-000287 001-40800 231021532 33 5182
2023-06-16 144 xsl144X01/primary_doc.xml 0001971857-23-000286 001-40800 231020833 33 11094
2023-06-15 4 FORM 4 SUBMISSION 0001209191-23-037613 14525
2023-06-15 4 FORM 4 SUBMISSION 0001209191-23-037611 19808
2023-06-02 4 FORM 4 SUBMISSION 0001209191-23-033788 5759
2023-06-02 4 FORM 4 SUBMISSION 0001209191-23-033786 5673
2023-06-02 4 FORM 4 SUBMISSION 0001209191-23-033769 5687
2023-06-02 4 FORM 4 SUBMISSION 0001209191-23-033780 6442
2023-06-02 4 FORM 4 SUBMISSION 0001209191-23-033779 6332
2023-06-02 4 OWNERSHIP DOCUMENT 0001104659-23-067591 14153
2023-06-02 4 FORM 4 SUBMISSION 0001209191-23-033775 5670
2023-06-02 4 FORM 4 SUBMISSION 0001209191-23-033774 5691
2023-06-02 8-K 8-K 5.07 0001193125-23-159845 001-40800 23988937 34 151321 1 1
2023-05-04 10-Q 10-Q 0000950170-23-017875 001-40800 23888968 34 6425651 1 1
2023-05-04 8-K 8-K 2.02,9.01 0000950170-23-017846 001-40800 23888717 34 317342 1 1
2023-04-17 ARS ARS 0001193125-23-103816 001-40800 23824662 34 3068422
2023-04-17 DEFA14A DEFA14A 0001193125-23-103806 001-40800 23824631 34 38357
2023-04-17 DEF 14A DEF 14A 0001193125-23-103757 001-40800 23824520 34 497156
2023-04-05 4 FORM 4 SUBMISSION 0001209191-23-023402 8923
2023-04-03 4 FORM 4 SUBMISSION 0001209191-23-022432 19133
2023-03-31 4 FORM 4 SUBMISSION 0001209191-23-021947 19105
2023-03-29 4 FORM 4 SUBMISSION 0001209191-23-021564 19133
2023-03-28 4 FORM 4 SUBMISSION 0001209191-23-021443 19100
2023-03-23 4 FORM 4 SUBMISSION 0001209191-23-020848 19108
2023-03-23 4 FORM 4 SUBMISSION 0001209191-23-020846 19135
2023-03-22 10-K 10-K 0000950170-23-009181 001-40800 23753122 34 14363501 1 1
2023-03-22 8-K 8-K 2.02,9.01 0000950170-23-009166 001-40800 23752949 34 362295 1 1
2023-03-17 4 FORM 4 SUBMISSION 0001209191-23-019793 4608
2023-03-17 4 FORM 4 SUBMISSION 0001209191-23-019791 4607
2023-03-01 8-K 8-K 5.02,8.01 0001193125-23-055156 001-40800 23689794 34 155925 1 1
2023-02-23 4 FORM 4 SUBMISSION 0001209191-23-012330 4579
2023-02-13 4 xslF345X03/form4.xml 0000895345-23-000107 7690
2023-02-09 SC 13G/A filing.txt 0000315066-23-002081 005-92865 23605074 34 8006
2023-01-03 4 FORM 4 SUBMISSION 0001209191-23-000300 7717
2023-01-03 3 FORM 3 SUBMISSION 0001209191-23-000291 7579
2022-11-29 8-K 8-K 8.01 0001193125-22-293899 001-40800 221428372 34 143125 1 1
2022-11-03 10-Q 10-Q 0000950170-22-021937 001-40800 221358610 34 7156726 1 1
2022-11-03 8-K 8-K 2.02,5.02,9.01 0000950170-22-021888 001-40800 221358255 34 388647 1 1
2022-10-14 4 FORM 4 SUBMISSION 0001209191-22-053692 4582
2022-10-13 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-10-13 16:00:00 9999999995-22-003041 333-267712 221310168 33 1631
2022-10-11 CORRESP filename1.htm 0001193125-22-260777 6309
2022-10-11 UPLOAD filename1.pdf 0000000000-22-011119 40096
2022-10-03 8-K 8-K 1.01,9.01 0001193125-22-256710 001-40800 221288032 34 150807 1 1
2022-10-03 S-3 S-3 0001193125-22-256638 333-267712 221287508 33 1768827
2022-09-19 4 FORM 4 SUBMISSION 0001209191-22-050612 4609
2022-09-19 4 FORM 4 SUBMISSION 0001209191-22-050613 5506
2022-09-19 4 FORM 4 SUBMISSION 0001209191-22-050601 4621
2022-09-19 4 FORM 4 SUBMISSION 0001209191-22-050599 4624
2022-09-08 4 FORM 4 SUBMISSION 0001209191-22-049219 15075
2022-09-08 4 FORM 4 SUBMISSION 0001209191-22-049218 11754
2022-09-08 4 FORM 4 SUBMISSION 0001209191-22-049217 11776
2022-09-08 4 FORM 4 SUBMISSION 0001209191-22-049216 14190
2022-09-08 4 FORM 4 SUBMISSION 0001209191-22-049215 11778
2022-09-08 4 FORM 4 SUBMISSION 0001209191-22-049213 11753
2022-09-08 4 FORM 4 SUBMISSION 0001209191-22-049212 12448
2022-08-04 10-Q 10-Q 0000950170-22-014802 001-40800 221137226 34 6445810 1 1
2022-08-04 8-K 8-K 2.02,9.01 0000950170-22-014777 001-40800 221136972 34 343390 1 1
2022-06-16 SC 13D/A SC 13D/A 0001193125-22-174956 005-92865 221019000 34 142194
2022-06-15 4 FORM 4 SUBMISSION 0001209191-22-037012 10317
2022-06-15 4 FORM 4 SUBMISSION 0001209191-22-036994 10988
2022-06-15 4 FORM 4 SUBMISSION 0001209191-22-036981 10318
2022-06-15 4 FORM 4 SUBMISSION 0001209191-22-036979 10343
2022-06-15 4 FORM 4 SUBMISSION 0001209191-22-036971 10403
2022-06-15 4 FORM 4 SUBMISSION 0001209191-22-036966 10325
2022-06-15 4 FORM 4 SUBMISSION 0001209191-22-036963 11084
2022-06-15 4 OWNERSHIP DOCUMENT 0001104659-22-071472 14177
2022-06-14 8-K 8-K 5.07 0001193125-22-173822 001-40800 221014686 34 149564 1 1
2022-05-16 4 FORM 4 SUBMISSION 0001209191-22-029441 9857
2022-05-16 3 FORM 3 SUBMISSION 0001209191-22-029437 7568
2022-05-05 10-Q 10-Q 0000950170-22-007879 001-40800 22896931 34 5539791 1 1
2022-05-05 8-K 8-K 2.02,9.01 0001193125-22-142331 001-40800 22896557 34 188138 1 1
2022-04-28 DEFA14A DEFA14A 0001193125-22-127568 001-40800 22866677 34 88396
2022-04-28 DEF 14A DEF 14A 0001193125-22-127537 001-40800 22866542 34 451188
2022-03-24 SC 13G THE SCHEDULE 13G 0000921895-22-000969 005-92865 22766796 34 285764
2022-03-03 3 FORM 3 SUBMISSION 0001209191-22-015869 8788
2022-03-03 10-K 10-K 0000950170-22-002814 001-40800 22709407 34 14914429 1 1
2022-03-03 8-K 8-K 2.02,9.01 0001193125-22-064358 001-40800 22708941 34 219964 1 1
2022-02-09 SC 13G filing.txt 0000315066-22-001211 005-92865 22604621 34 8268
2022-02-08 SC 13G SC 13G 0001193125-22-030948 005-92865 22600891 34 111011
2021-12-21 4 FORM 4 SUBMISSION 0000899243-21-049181 9127
2021-11-04 4 FORM 4 SUBMISSION 0001209191-21-063023 9787
2021-11-04 4 FORM 4 SUBMISSION 0001209191-21-063021 9792
2021-11-04 4 FORM 4 SUBMISSION 0001209191-21-063019 9782
2021-11-04 4 FORM 4 SUBMISSION 0001209191-21-063017 9795
2021-11-04 4 FORM 4 SUBMISSION 0001209191-21-063014 9795
2021-11-04 4 FORM 4 SUBMISSION 0001209191-21-063012 9786
2021-11-04 4 FORM 4 SUBMISSION 0001209191-21-063010 9790
2021-11-03 10-Q 10-Q 0000950170-21-002837 001-40800 211375940 34 7986947 1 1
2021-11-03 8-K 8-K 2.02,7.01,9.01 0001193125-21-318435 001-40800 211375597 34 207940 1 1
2021-09-29 SC 13G/A AMENDMENT NO. 1 0001214659-21-009865 005-92865 211289109 34 42957
2021-09-27 SC 13G SCHEDULE 13G 0001104659-21-119801 005-92865 211282105 34 115214
2021-09-27 SC 13D SC 13D 0001104659-21-119793 005-92865 211282066 34 132927
2021-09-27 SC 13D SCHEDULE 13D 0001104659-21-119792 005-92865 211282057 34 115403
2021-09-24 SC 13D SC 13D 0001193125-21-282389 005-92865 211277712 34 123299
2021-09-21 4 FORM 4 0001567619-21-017389 15827
2021-09-21 SC 13G p921210sc13g.htm 0001214659-21-009668 005-92865 211265568 34 43001
2021-09-20 4/A FORM 4/A SUBMISSION 0000899243-21-036637 15073
2021-09-20 4 FORM 4 SUBMISSION 0000899243-21-036606 19619
2021-09-17 4 FORM 4 SUBMISSION 0000899243-21-036432 6981
2021-09-17 4 FORM 4 SUBMISSION 0000899243-21-036431 11750
2021-09-17 4 FORM 4 SUBMISSION 0000899243-21-036429 17221
2021-09-17 4 FORM 4 SUBMISSION 0000899243-21-036427 8035
2021-09-17 4 FORM 4 SUBMISSION 0000899243-21-036426 6981
2021-09-17 4 FORM 4 SUBMISSION 0000899243-21-036424 9298
2021-09-17 4 FORM 4 SUBMISSION 0000899243-21-036420 14667
2021-09-17 4 FORM 4 SUBMISSION 0000899243-21-036419 24315
2021-09-17 4 OWNERSHIP DOCUMENT 0001104659-21-116944 29652
2021-09-17 8-K 8-K 5.03,8.01,9.01 0001193125-21-276124 001-40800 211260369 34 244372
2021-09-15 S-8 S-8 0001193125-21-274128 333-259560 211256075 33 81308
2021-09-15 424B4 424B4 0001193125-21-273963 333-258970 211255534 33 5219501
2021-09-14 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2021-09-14 16:00:00 9999999995-21-003510 333-258970 211254133 33 1631
2021-09-14 3 FORM 3 SUBMISSION 0000899243-21-035962 12185
2021-09-14 3 FORM 3 SUBMISSION 0000899243-21-035955 7925
2021-09-14 3 FORM 3 SUBMISSION 0000899243-21-035954 9099
2021-09-14 3 FORM 3 SUBMISSION 0000899243-21-035952 12463
2021-09-14 3 FORM 3 SUBMISSION 0000899243-21-035949 12076
2021-09-14 3 FORM 3 SUBMISSION 0000899243-21-035948 7921
2021-09-14 3 FORM 3 SUBMISSION 0000899243-21-035944 12713

Latest XBRL company facts

One latest value per concept from companyfacts (213 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 69.08M 2026-11-06 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
dei EntityListingParValuePerShare Entity Listing, Par Value Per Share USD/shares 0 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-05 0001193125-25-266967
dei EntityPublicFloat Entity Public Float USD 297.30M 2025-06-30 2025 FY 10-K 2026-03-02 0001193125-26-085490
ffd NetFeeAmt NetFeeAmt USD 55,241.43 2026-09-14 424B5 2026-09-15 0001193125-26-390947
ffd NrrtvMaxAggtOfferingPric NrrtvMaxAggtOfferingPric USD 400.01M 2026-09-14 424B5 2026-09-15 0001193125-26-390947
ffd TtlFeeAmt TtlFeeAmt USD 55,241.43 2026-09-14 424B5 2026-09-15 0001193125-26-390947
ffd TtlOfferingAmt TtlOfferingAmt USD 400.01M 2026-09-14 424B5 2026-09-15 0001193125-26-390947
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-09-14 424B5 2026-09-15 0001193125-26-390947
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-09-14 424B5 2026-09-15 0001193125-26-390947
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 3.30M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap AccountsPayableRelatedPartiesCurrent Accounts Payable, Related Parties, Current USD 0 2022-12-31 2022 FY 10-K 2023-03-22 0000950170-23-009181
us-gaap AccruedEmployeeBenefitsCurrent Accrued Employee Benefits, Current USD 634,000 2021-09-30 2021 Q3 10-Q 2021-11-03 0000950170-21-002837
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 853,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap AccruedSalariesCurrent Accrued Salaries, Current USD 6.82M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 1.39M 2025-03-31 2025 Q1 10-Q 2025-05-08 0000950170-25-066942
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -1.28M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 1.20B 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 12.16M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 30.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 14.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap Assets Assets USD 727.53M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap AssetsCurrent Assets, Current USD 711.62M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap AssetsFairValueAdjustment Assets, Fair Value Adjustment USD 0 2025-01-01 2025-12-31 2026 Q1 10-Q 2026-05-13 0001193125-26-220645
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 245.82M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap AvailableForSaleDebtSecuritiesGrossUnrealizedGain Debt Securities, Available-for-sale, Unrealized Gain USD 231,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-13 0001193125-26-220645
us-gaap AvailableForSaleDebtSecuritiesGrossUnrealizedLoss Debt Securities, Available-for-sale, Unrealized Loss USD 124,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-13 0001193125-26-220645
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 244.53M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap CapitalUnitsAuthorized Capital Units, Authorized shares 550.00M 2021-09-17 2021 Q3 10-Q 2021-11-03 0000950170-21-002837
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 456.02M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 457.02M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 378.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0.001 2026-09-15 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 15.46M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 6.38M 2026-03-31 2026 Q1 10-Q 2026-05-13 0001193125-26-220645
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 34.27M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 500.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 68.98M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 68.98M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap CommonStockValue Common Stock, Value, Issued USD 7,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -137.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions Security 70 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss USD 27,000 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-085490
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 1.44M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-085490
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 89.47M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-085490
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-085490
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 1.44M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-085490
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 41.79M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-085490
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 2.29M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-085490
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 4.57M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-085490
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 88.03M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-085490
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 1.18M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-085490
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 85,000 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-085490
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 175,000 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-085490
us-gaap DefinedBenefitPlanContributionsByEmployer Defined Benefit Plan, Plan Assets, Contributions by Employer USD 600,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-085490
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-085490
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent pure 0.04 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-085490
us-gaap Depreciation Depreciation USD 100,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-08 0000950170-25-066942
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 406,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap EarlyRepaymentOfSubordinatedDebt Early Repayment of Subordinated Debt USD 25,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-03 0000950170-22-002814
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -2.07 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.36 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-05 0000950170-22-007879
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -2.07 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-085490
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-085490
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.198 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-085490
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-085490
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.014 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-085490
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.011 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-085490
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.054 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-085490
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 17.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 13.00B 2022-09-30 2022 Q3 10-Q 2022-11-03 0000950170-22-021937
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 74.40M 2026-03-31 2026 Q1 10-Q 2026-05-13 0001193125-26-220645
us-gaap EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense Share-based Payment Arrangement, Expense, Tax Benefit USD 200,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0000950170-24-123346
us-gaap FairValueOptionCreditRiskGainsLossesOnAssets Fair Value, Option, Credit Risk, Gains (Losses) on Assets USD 25.92M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-02 0001193125-26-085490
us-gaap FinanceLeaseInterestExpense Finance Lease, Interest Expense USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-03 0000950170-22-002814
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 0 2021-09-30 2021 Q3 10-Q 2021-11-03 0000950170-21-002837
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-22 0000950170-23-009181
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 0 2021-09-30 2021 Q3 10-Q 2021-11-03 0000950170-21-002837
us-gaap FinanceLeaseRightOfUseAssetAmortization Finance Lease, Right-of-Use Asset, Amortization USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-22 0000950170-23-009181
us-gaap FinanceLeaseWeightedAverageDiscountRatePercent Finance Lease, Weighted Average Discount Rate, Percent pure 0.075 2021-12-31 2021 FY 10-K 2022-03-03 0000950170-22-002814
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -4,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-19 0000950170-24-033461
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 30.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss Debt Securities, Held-to-maturity, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss USD 0 2025-06-30 2025 Q2 10-Q 2025-08-14 0000950170-25-108899
us-gaap HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss Debt Securities, Held-to-maturity, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss USD 16,000 2025-06-30 2025 Q2 10-Q 2025-08-14 0000950170-25-108899
us-gaap HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue Debt Securities, Held-to-maturity, Continuous Unrealized Loss Position, Less than 12 Months, Fair Value USD 34.31M 2025-06-30 2025 Q2 10-Q 2025-08-14 0000950170-25-108899
us-gaap HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue Debt Securities, Held-to-maturity, Continuous Unrealized Loss Position, 12 Months or Longer, Fair Value USD 0 2025-06-30 2025 Q2 10-Q 2025-08-14 0000950170-25-108899
us-gaap IncomeTaxExaminationPenaltiesAndInterestAccrued Income Tax Examination, Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-085490
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-085490
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 23.68M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-085490
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -25.19M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-085490
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 46,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-085490
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 1.65M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-085490
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -1.33M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-085490
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 6.41M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-085490
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 11.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap IncreaseDecreaseInPrepaidExpensesOther Increase (Decrease) in Prepaid Expenses, Other USD 1.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap InterestAndOtherIncome Interest and Other Income USD 9.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-03 0000950170-22-002814
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 8,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-03 0000950170-21-002837
us-gaap LeaseCost Lease, Cost USD 908,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 7.14M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 3.04M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 229,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 1.01M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 983,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 955,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 927,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 216,000 2024-09-30 2024 Q3 10-Q 2024-11-07 0000950170-24-123346
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 1.68M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap Liabilities Liabilities USD 34.68M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 727.53M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap LiabilitiesCurrent Liabilities, Current USD 29.74M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap LineOfCredit Long-term Line of Credit USD 200,000 2021-12-31 2021 FY 10-K 2022-03-03 0000950170-22-002814
us-gaap LossContingencyAccrualAtCarryingValue Loss Contingency Accrual USD 0 2022-09-30 2022 Q3 10-Q 2022-11-03 0000950170-22-021937
us-gaap MarketableSecurities Marketable Securities USD 244.53M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 541.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -67.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -95.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -135.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 9.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-22 0000950170-23-009181
us-gaap NumberOfPropertiesSubjectToGroundLeases Number of Properties Subject to Ground Leases Segment 2 2026-03-31 2026 Q1 10-Q 2026-05-13 0001193125-26-220645
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap OperatingExpenses Operating Expenses USD 145.89M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -145.89M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap OperatingLeaseCost Operating Lease, Cost USD 718,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 5.46M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 521,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 4.94M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap OperatingLeasePayments Operating Lease, Payments USD 700,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 5.18M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.081 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 25.92M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 8.76M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent USD -1.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 0 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-085490
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 39,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-19 0000950170-24-033461
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -28,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-07 0000950170-23-060276
us-gaap OtherSellingGeneralAndAdministrativeExpense Other Selling, General and Administrative Expense USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-19 0000950170-24-033461
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 2.10M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-04 0001193125-26-332995
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 203.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 244,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 50.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 11.07M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-22 0000950170-23-009181
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 147.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 120.56M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-02 0001193125-26-085490
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised USD 450,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-03 0000950170-22-002814
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 136.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap ProceedsFromSaleOfOtherPropertyPlantAndEquipment Proceeds from Sale of Other Property, Plant, and Equipment USD 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-03 0000950170-22-021937
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-22 0000950170-23-009181
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 89,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-03 0000950170-22-002814
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 2.92M 2025-03-31 2025 Q1 10-Q 2025-05-08 0000950170-25-066942
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 1.08M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party USD 0 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-04 0000950170-23-017875
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 115.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap RestrictedCash Restricted Cash USD 1.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 1.00M 2025-03-31 2025 Q1 10-Q 2025-05-08 0000950170-25-066942
us-gaap RestrictedCashAndInvestmentsCurrent Restricted Cash and Investments, Current USD 116,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 884,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -507.24M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046124
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-07 0000950170-23-060276
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 30.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost Share-based Payment Arrangement, Accelerated Cost USD 2.00M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-02 0001193125-26-085490
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 282,205 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-03 0000950170-22-021937
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.886 2024-01-01 2024-03-31 2025 Q1 10-Q 2025-05-08 0000950170-25-066942
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.042 2024-01-01 2024-03-31 2025 Q1 10-Q 2025-05-08 0000950170-25-066942
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 71.68M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 7.10M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 12.19 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 160.26M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-13 0001193125-26-220645
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 866,670 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 14.98 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 3.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 2.7 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-03 0000950170-21-002837
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 105.37M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 14.42M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 16.92 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 105.37M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 14.42M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 16.92 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 600,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-03 0000950170-21-002837
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent pure 0.85 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0000950170-24-123346
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 11.41 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 16.64 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-03 0000950170-22-021937
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 33 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 22.03 2026-09-15 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap SharesOutstanding Shares, Outstanding shares 2.37M 2021-06-30 2022 Q3 10-Q 2022-11-03 0000950170-22-021937
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 71,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 692.84M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0 2021-09-07 2022 Q3 10-Q 2022-11-03 0000950170-22-021937
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 1.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 157.27M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-22 0000950170-23-009181
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 181.22M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-22 0000950170-23-009181
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 632,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-19 0000950170-24-033461
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 0 2021-12-31 2021 FY 10-K 2022-03-03 0000950170-22-002814
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 8.71M 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-085490
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 2.04M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-085490
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 1.13M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-085490
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 24.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-085490
us-gaap VariableLeaseCost Variable Lease, Cost USD 119,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap WeightedAverageBasicSharesOutstandingProForma Weighted Average Basic Shares Outstanding, Pro Forma shares 61.75M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-13 0001193125-26-220645
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 65.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 41.55M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-05 0000950170-22-007879
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 65.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454481

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →